Press release
Pharmaceutical CDMO Market Size (USD 250.07 M) by 2032 | With CAGR of 7.7%
Pharmaceutical CDMO Market Size 2024-2032
Pharmaceutical CDMO Market size was USD 128.27 Million in 2023 and is projected to touch USD 138.14 Million in 2024 to USD 250.07 Million by 2032, exhibiting a CAGR of 7.7% during the forecast period [2024-2032].
Get a Sample PDF of Pharmaceutical CDMO Market 2024 @ https://www.globalgrowthinsights.com/enquiry/request-sample-pdf/pharmaceutical-cdmo-market-101455
About Pharmaceutical CDMO Market Report:
The Pharmaceutical CDMO market analysis provides a comprehensive evaluation of the top market players, their product descriptions, business overviews, and strategies. It further highlights production volumes, future demand forecasts, raw material needs, and the financial health of organizations.
List of Key Pharmaceutical CDMO Companies Profiled
Lonza - Headquarters: Basel, Switzerland, Revenue: CHF 6.2 billion (2023)
Catalent - Headquarters: Somerset, New Jersey, USA, Revenue: $4.8 billion (2023)
Thermo Fisher Scientific - Headquarters: Waltham, Massachusetts, USA, Revenue: $44.9 billion (2023)
Samsung Biologics - Headquarters: Incheon, South Korea, Revenue: $2.3 billion (2023)
Fareva - Headquarters: Luxembourg, Revenue: $1.8 billion (2023)
WuXi AppTec - Headquarters: Shanghai, China, Revenue: RMB 45 billion (2023)
WuXi Biologics - Headquarters: Wuxi, China, Revenue: RMB 10.4 billion (2023)
Siegfried - Headquarters: Zofingen, Switzerland, Revenue: CHF 1.2 billion (2023)
FUJIFILM Diosynth Biotechnologies - Headquarters: Morrisville, North Carolina, USA, Revenue: $2 billion (2023)
Asymchem - Headquarters: Tianjin, China, Revenue: $950 million (2023)
Pfizer CentreOne - Headquarters: New York, USA, Revenue: $81.3 billion (2023) (Pfizer total revenue)
Delpharm - Headquarters: Boulogne-Billancourt, France, Revenue: €650 million (2023)
Recipharm - Headquarters: Stockholm, Sweden, Revenue: SEK 13 billion (2023)
AGC Pharma Chemicals - Headquarters: Tokyo, Japan, Revenue: $3.6 billion (2023) (AGC total revenue)
Boehringer Ingelheim - Headquarters: Ingelheim, Germany, Revenue: €24.1 billion (2023)
Vetter - Headquarters: Ravensburg, Germany, Revenue: €670 million (2023)
Curia - Headquarters: Albany, New York, USA, Revenue: $900 million (2023)
Aenova - Headquarters: Starnberg, Germany, Revenue: €760 million (2023)
Porton - Headquarters: Chongqing, China, Revenue: $680 million (2023)
Piramal - Headquarters: Mumbai, India, Revenue: $2.6 billion (2023)
Strides Pharma - Headquarters: Bangalore, India, Revenue: $850 million (2023)
NextPharma - Headquarters: Göttingen, Germany, Revenue: €500 million (2023)
Famar - Headquarters: Paris, France, Revenue: €350 million (2023)
Jubilant - Headquarters: Noida, India, Revenue: $1.2 billion (2023)
Alcami - Headquarters: Wilmington, North Carolina, USA, Revenue: $400 million (2023)
Euroapi - Headquarters: Paris, France, Revenue: €1.1 billion (2023)
Eurofins - Headquarters: Luxembourg, Revenue: €7.1 billion (2023)
Avid Bioservices - Headquarters: Tustin, California, USA, Revenue: $150 million (2023)
BioVectra - Headquarters: Charlottetown, Canada, Revenue: $125 million (2023)
CPL (Contract Pharmaceuticals Limited) - Headquarters: Mississauga, Canada, Revenue: $100 million (2023)
The report offers valuable insights into various business aspects, such as foundational pillars, sales strategies, planning models, and recent technological advancements. It also emphasizes tools, methodologies, and recent developments that help propel industry performance.
The Pharmaceutical CDMO Market report thoroughly analyzes every sub-segment regarding individual growth trends, their contribution to the overall market, and the upcoming forecasts.
Market Segmentation by Product Type:
Active Pharmaceutical Ingredient (API) Manufacturing
Finished Dosage Formulation (FDF) Development and Manufacturing
Secondary Packaging
Market Segmentation by Application:
Small & Mid-Size Pharma Companies
Generic Pharmaceutical Companies
Big Pharma Companies
Others
Request PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @https://www.globalgrowthinsights.com/market-reports/pharmaceutical-cdmo-market-101455
Frequently Asked Questions (FAQ)
What are the present scale and future growth prospects of the Pharmaceutical CDMO Market?
Answer: Pharmaceutical CDMO Market size was USD 128.27 Million in 2023 and is projected to touch USD 138.14 Million in 2024 to USD 250.07 Million by 2032, exhibiting a CAGR of 7.7% during the forecast period [2024-2032].
What is the current state of the Pharmaceutical CDMO market?
Answer: As of the latest data, the Pharmaceutical CDMO market is experiencing growth, stability, and challenges.
Who are the key players in the Pharmaceutical CDMO market?
Answer: Prominent players in the Pharmaceutical CDMO market include key companies, known for their notable characteristics or strengths.
What factors are driving the growth of the Pharmaceutical CDMO market?
Answer: The growth of the Pharmaceutical CDMO market can be attributed to factors such as key drivers technological advancements, increasing demand, and regulatory support.
Are there any challenges affecting the Pharmaceutical CDMO market?
Answer: The Pharmaceutical CDMO market's challenges include competition, regulatory hurdles, and economic factors.
How is the competitive landscape in the Pharmaceutical CDMO market?
Answer: The competitive landscape is characterized by the competitive dynamics - key players, market share, and strategies.
What are the key trends shaping the Pharmaceutical CDMO market?
Answer: Current trends in the Pharmaceutical CDMO market include significant technological innovations and changing consumer preferences.
Key Benefits of the Report:
Insights into key players and their recent developments.
Mapping of major countries based on market revenue.
In-depth analysis of factors driving and restricting market growth.
Comprehensive overview of current research and clinical developments.
Reason to Purchase the Pharmaceutical CDMO Market Report:
Understand the global Pharmaceutical CDMO market, including estimates, scope, and divisions.
Competitive analysis of leading players, production values, and pricing structures.
Focus on top Pharmaceutical CDMO manufacturers' future plans, capacity, production, and market share.
Identify emerging sectors, opportunities, and policies shaping the market.
Current global market status, including regional breakdowns.
Identify high-growth segments to capitalize on market opportunities.
Purchase this report (Price 3950 USD for a SUL) @ https://www.globalgrowthinsights.com/checkout-page/101455
5 Recent Developments
Lonza's Expansion in Biologics: In 2023, Lonza announced a significant expansion of its biologics manufacturing capabilities, adding new facilities in Switzerland and the U.S. to meet the growing demand for biologic drugs, including mRNA therapies and cell therapies.
Catalent's Acquisition of Bettera Holdings: Catalent, in late 2023, acquired Bettera Holdings, a company specializing in nutraceuticals and soft gels, expanding its product portfolio and solidifying its position in the nutraceutical market, which complements its pharmaceutical services.
Samsung Biologics' New Facility: Samsung Biologics opened its fourth and largest biomanufacturing facility in Incheon, South Korea, in 2023, increasing its production capacity and positioning itself as a global leader in biologics manufacturing.
Thermo Fisher Scientific's Acquisition of PPD: Thermo Fisher completed its acquisition of PPD, a leading contract research organization (CRO), in 2023, strengthening its capabilities in clinical trials and drug development services.
WuXi Biologics' Expansion in Europe: WuXi Biologics announced the establishment of a new facility in Germany in 2023, marking its first biologics manufacturing plant in Europe, aimed at serving European clients and expanding its global footprint.
This Global Pharmaceutical CDMO Industry 2024 Market Research Report provides essential statistics, trends, and a competitive landscape analysis in this dynamic sector.
Global Growth Insights
Office No.- B, 2nd Floor, Icon Tower,
Baner-Mhalunge Road, Baner,
Pune 411045, Maharashtra, India.
Toll-Free Numbers:
US : +1 (855) 467-7775
UK : +44 8085 022397
Email: sales@globalgrowthinsights.com
Global Growth Insights is a unique organization that offers expert analysis and accurate data-based market intelligence, aiding companies of all shapes and sizes to make well-informed decisions. We tailor inventive solutions for our clients, helping them tackle any challenges that are likely to emerge from time to time and affect their businesses. At Global Growth Insights, our principal goal is to empower our customers with a granular market analysis while incorporating a panoramic overview of the market they are intending to enter and establish themselves. Our customized reports contain a niche and unparalleled mix of tangible insights and qualitative evaluation of factors shaping the market to support companies achieve sustainable growth. Our team of experienced analysts and consultants employs standard research tools and techniques to collate and present comprehensive market studies substantiated with relevant data. Here are some of the key areas we focus on while crafting your report.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmaceutical CDMO Market Size (USD 250.07 M) by 2032 | With CAGR of 7.7% here
News-ID: 3677938 • Views: …
More Releases from Global Growth Insights
Dermatology Drug Market Growth Opportunities by Application: Comprehensive Forec …
[No. of pages: 102] This Global Dermatology Drug Market research report provides a complete overview of the market by examining it both qualitatively and statistically, including particular data and in-depth insights from several market segments. While the qualitative analysis of market dynamics, which includes growth drivers, challenges, constraints, and so on, offers in-depth insight into the market's current and potential, the quantitative analysis includes historical and forecast statistics of major…
Commercial Drones Market Future Trends and Size Analysis for 2024 - 2032
[No. of pages: 126] This Global Commercial Drones Market research report provides a complete overview of the market by examining it both qualitatively and statistically, including particular data and in-depth insights from several market segments. While the qualitative analysis of market dynamics, which includes growth drivers, challenges, constraints, and so on, offers in-depth insight into the market's current and potential, the quantitative analysis includes historical and forecast statistics of major…
Herpes Treatment Market Application Analysis and Size Projections: Future Outloo …
[No. of pages: 121] This Global Herpes Treatment Market research report provides a complete overview of the market by examining it both qualitatively and statistically, including particular data and in-depth insights from several market segments. While the qualitative analysis of market dynamics, which includes growth drivers, challenges, constraints, and so on, offers in-depth insight into the market's current and potential, the quantitative analysis includes historical and forecast statistics of major…
Magnetic Nanoparticles Market Overview Report: Trends, Size, and Future Projecti …
[No. of pages: 107] This Global Magnetic Nanoparticles Market research report provides a complete overview of the market by examining it both qualitatively and statistically, including particular data and in-depth insights from several market segments. While the qualitative analysis of market dynamics, which includes growth drivers, challenges, constraints, and so on, offers in-depth insight into the market's current and potential, the quantitative analysis includes historical and forecast statistics of major…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
